Literature DB >> 23285317

Implant rehabilitation in patients irradiated for head and neck cancer: role of Intensity-Moduled Radiotherapy (IMRT) in planning the insertion site.

Fabrizio Carini1, Valeria Pisapia, Dario Monai, Lorena Barbano, Gianluca Porcaro.   

Abstract

PURPOSE: currently, head and neck irradiation is not considered an absolute contraindication for implant placement (1), especially due to the transition from conventional to conformal radiotherapy. However, there is a difference in the success rate of implant placement between irradiated and non-irradiated bones (5). Successful osseointegration is mainly affected by the total dose of radiation (6). The main purpose of this study was to minimize problems related to radiation dose by evaluating in advance the most suitable site for implant insertion on the basis of the mean absorbed dose. Additional aims were: to estimate the appropriate timing for implant insertion in irradiated bones, to analyze the difference in stability between maxilla and mandible, and to evaluate the success of implants with wrinkled microgeometry and increased layer of TiO(2).
MATERIALS AND METHODS: five patients who had been irradiated for head and neck cancer using intensity-modulated radiotherapy (IMRT) were recruited for our study. Surgical procedures were performed following a pre-surgical evaluation of the correct insertion position of implant fixtures. The latter was based on a scrutiny of dose-volume histograms (DVH) developed by a team of experts in medical physics and radiotherapists after dentists had contoured the volumes of interest. Student's t test and Pearson's correlation test were used for comparison and correlation between the variables considered.
RESULTS: the percentage of osseointegration was 100%, which supports the usefulness of the adopted technique. A statistically significant difference in stability and crestal bone resorption emerged in the comparison between maxilla and mandible, but not between times of insertion. Moreover, there was a significant correlation between radiation dose and ISQ values: an increase in radiation dose corresponded to a decrease in primary stability. However, the correlation between ISQ values and implant length was not significant as well as that between primary stability and implant diameter.
CONCLUSIONS: implantology guided by assessment of absorbed irradiation dose in the site to be rehabilitated can lead both to an increase in implant survival into irradiated tissue bone, and to a reduction in the incidence of ORN. However, both a larger sample size and the development of long-term prospective studies are necessary to validate the described method.

Entities:  

Keywords:  IMRT; contouring; implants rehabilitation

Year:  2012        PMID: 23285317      PMCID: PMC3512556     

Source DB:  PubMed          Journal:  Ann Stomatol (Roma)        ISSN: 1824-0852


  23 in total

1.  A clinical evaluation of implants in irradiated oral cancer patients.

Authors:  L L Visch; M A J van Waas; P I M Schmitz; P C Levendag
Journal:  J Dent Res       Date:  2002-12       Impact factor: 6.116

2.  Survival of dental implants in native and grafted bone in irradiated head and neck cancer patients: a retrospective analysis.

Authors:  Aravind Buddula; Daniel A Assad; Thomas J Salinas; Yolanda I Garces
Journal:  Indian J Dent Res       Date:  2011 Sep-Oct

Review 3.  Dental implants for patients who have had radiation treatment for head and neck cancer.

Authors:  Jody S Harrison; Scott Stratemann; Spencer W Redding
Journal:  Spec Care Dentist       Date:  2003 Nov-Dec

4.  Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy.

Authors:  M Parliament; M Alidrisi; M Munroe; J Wolfaardt; R Scrimger; H Thompson; C Field; E Kurien; J Hanson
Journal:  Int J Oral Maxillofac Surg       Date:  2005-03       Impact factor: 2.789

Review 5.  Oral implants in radiated patients: a systematic review.

Authors:  Giuseppe Colella; Rosangela Cannavale; Monica Pentenero; Sergio Gandolfo
Journal:  Int J Oral Maxillofac Implants       Date:  2007 Jul-Aug       Impact factor: 2.804

6.  Dental considerations and treatment of the oncology patient receiving radiation therapy.

Authors:  S J Meraw; C M Reeve
Journal:  J Am Dent Assoc       Date:  1998-02       Impact factor: 3.634

7.  Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions.

Authors:  Merav A Ben-David; Maximiliano Diamante; Jeffrey D Radawski; Karen A Vineberg; Cynthia Stroup; Carol-Anne Murdoch-Kinch; Samuel R Zwetchkenbaum; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-22       Impact factor: 7.038

8.  Risk factor assessment for the development of osteoradionecrosis.

Authors:  Batya R Goldwaser; Sung-Kiang Chuang; Leonard B Kaban; Meredith August
Journal:  J Oral Maxillofac Surg       Date:  2007-11       Impact factor: 1.895

9.  Studies in the radiobiology of osteoradionecrosis and their clinical significance.

Authors:  R E Marx; R P Johnson
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1987-10

10.  Survival analysis and clinical evaluation of implant-retained prostheses in oral cancer resection patients over a mean follow-up period of 10 years.

Authors:  Katja Nelson; Susanne Heberer; Corvin Glatzer
Journal:  J Prosthet Dent       Date:  2007-11       Impact factor: 3.426

View more
  2 in total

1.  Fabrication of an rhBMP-2 loaded porous β-TCP microsphere-hyaluronic acid-based powder gel composite and evaluation of implant osseointegration.

Authors:  Jae Hyup Lee; Jungju Kim; Hae-Ri Baek; Kyung Mee Lee; Jun-Hyuk Seo; Hyun-Kyung Lee; A-Young Lee; Guang Bin Zheng; Bong-Soon Chang; Choon-Ki Lee
Journal:  J Mater Sci Mater Med       Date:  2014-06-14       Impact factor: 3.896

2.  Implant-prosthetic rehabilitation after radiation treatment in head and neck cancer patients: a case-series report of outcome.

Authors:  Jasna Cotic; Jure Jamsek; Milan Kuhar; Natasa Ihan Hren; Andrej Kansky; Mutlu Özcan; Peter Jevnikar
Journal:  Radiol Oncol       Date:  2016-02-07       Impact factor: 2.991

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.